B1Flagship platform
Protein engineering · Fibrinolytic variants
Rank hundreds of variants without purifying each one. A cell-free expression platform scores
staphylokinase variants by activity directly from unpurified reactions — built for engineering
campaigns where variant numbers make conventional screening impractical.
- Cell-free screening
- High-throughput ranking
- Protein engineering
- Evidence
- Publication reported 2026 · data package under NDA
- Stage
- Pilot-ready · co-development open
- Indicative
- € 12 000 – 60 000co-development quoted individually
B2
Enzyme engineering · Directed evolution
Carbon–halogen bond cleavage for remediation and industrial process chemistry. Directed
evolution, ribosome display and catalytic optimisation applied to your substrate — relevant
wherever a process generates or handles halogenated streams.
- Biocatalysis
- Bioremediation
- Green chemistry
- Evidence
- Capability & method data under NDA
- Stage
- Pilot-ready · licensing open
- Indicative
- € 15 000 – 120 000negotiable by scope and application
B3
Protein biophysics · Formulation support
Know before you formulate. DSC, fluorescence probes and dynamic light scattering map
thermodynamic and kinetic stability; buffer, salt and pH screening and aggregation risk
profiling are run on your protein rather than on a generic prediction.
- Thermal stability
- Aggregation risk
- Buffer optimisation
- Evidence
- Method portfolio · report under NDA
- Stage
- Pilot-ready
- Indicative
- € 8 000 – 50 000negotiable by scope and application